This $2,623,234 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports the development of a wearable multiplex biosensor system to monitor exacerbation risk in patients with chronic obstructive pulmonary disease (COPD).
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center is the prime awardee, collaborating with researchers at the California Institute of Technology (Caltech) as a sub-grantee. The Lundquist Institute and Caltech team will focus on developing and optimizing the wearable biosensors to quantify biomarkers like sweat cortisol, C-reactive protein, and B-type natriuretic peptide, as well as creating the integrated wearable platform and data analytics to predict COPD exacerbations. This award aims to advance innovative biomedical solutions to improve healthcare for military service members and the broader population.
Generated 12/10/24, 11:25 AM